Scleroderma
📧 Sign up to get email alerts when something new happens for Scleroderma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-13Clinical Trial Results: TENS in Scleroderma [NA]
Completed clinical trial results for TENS in scleroderma (systemic sclerosis) and gastroparesis, posted in 2026.
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Efficacy of Tofacitinib on Skin Thickening in Diffuse Cutaneous Systemic Sclerosis: A Comparative Study With Methotrexate [Phase 4]
Phase 4 trial evaluating the efficacy of tofacitinib on skin thickening in diffuse cutaneous systemic sclerosis, compared with methotrexate;…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease
A ClinicalTrials.gov update describes a biospecimen collection study led by TScan Therapeutics to identify targets of disease-reactive T cel…
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Patients Diagnosed With Scleroderma and Their Chewing and Swallowing Performance
This clinical trial update notes that a study sponsored by Hacettepe University is recruiting participants to evaluate chewing and swallowin…
-
CLINICAL_TRIALS trial_result · 2023-12-15Clinical Trial Update: Scleroderma Lung Study III - Combining Pirfenidone With Mycophenolate [Phase 2]
A Phase 2 trial updating on combining pirfenidone with mycophenolate for scleroderma-associated interstitial lung disease has completed with…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2023-02-01Clinical Trial Update: Evaluation of the Scleroderma Patient-centered Intervention Network COVID-19 Home-isolation Activities Together Program [NA]
A completed clinical trial evaluating a home-based intervention for people with scleroderma (systemic sclerosis) undergoing COVID-19 isolati…
-
CLINICAL_TRIALS trial_result · 2023-01-17Clinical Trial Update: COvid-19 Vaccine Booster in Immunocompromised Rheumatic Diseases [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial update evaluating a COVID-19 vaccine booster in immunocompromised individuals with rheumatic diseases.
-
CLINICAL_TRIALS trial_result · 2022-06-24Clinical Trial Update: A Study of FCX-013 Plus Veledimex for the Treatment of Moderate to Severe Localized Scleroderma (Morphea) [Phase 1, Phase 2]
A clinical trial evaluating FCX-013 plus Veledimex in moderate to severe localized scleroderma (morphea) was terminated; results were posted…
-
CLINICAL_TRIALS trial_result · 2021-10-07Clinical Trial Update: Rituximab Versus Cyclophosphamide in Connective Tissue Disease-ILD [Phase 2, Phase 3]
A Phase 2/Phase 3 trial comparing rituximab to cyclophosphamide in connective tissue disease–associated interstitial lung disease has comple…
-
CLINICAL_TRIALS trial_result · 2021-08-25Clinical Trial Update: Comparing and Combining Bortezomib and Mycophenolate in SSc Pulmonary Fibrosis [Phase 2]
Phase 2 trial evaluating the combination of bortezomib and mycophenolate in interstitial lung disease associated with systemic sclerosis (sc…
-
CLINICAL_TRIALS trial_result · 2021-07-28Clinical Trial Update: Scleroderma Patient-centered Intervention Network (SPIN) Hand Program Feasibility Study [NA]
Feasibility study results for the SPIN Hand Program in scleroderma patients have been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-05-24Clinical Trial Update: Proof of Mechanism Study of GSK2330811 in Diffuse Cutaneous Systemic Sclerosis [Phase 2]
Phase 2 proof-of-mechanism study of GSK2330811 in diffuse cutaneous systemic sclerosis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-11-09Clinical Trial Update: A Study to Test Whether Nintedanib Influences the Components of Birth-control Pills in Women With Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD) [Phase 1]
Phase 1 trial studying whether nintedanib affects components of birth-control pills in women with systemic sclerosis-associated interstitial…
-
CLINICAL_TRIALS trial_result · 2020-08-12Clinical Trial Update: Atorvastatin for Microvascular Endothelial Function and Raynaud in Early Diffuse Scleroderma [Phase 2]
Phase 2 trial investigating atorvastatin for microvascular endothelial function and Raynaud phenomenon in early diffuse cutaneous systemic s…
-
CLINICAL_TRIALS trial_result · 2020-08-12Clinical Trial Update: Cardiac Safe Transplants for Systemic Sclerosis [Phase 2, Phase 3]
Clinical trial update for a cardiac-safe transplant approach in systemic sclerosis/scleroderma completed phases 2 and 3; status terminated w…
-
CLINICAL_TRIALS trial_result · 2020-07-23Clinical Trial Update: Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial [Phase 3]
Phase 3 trial of autologous stem cell systemic sclerosis immune suppression has been terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-05-08Clinical Trial Update: Evaluation of Tofacitinib in Early Diffuse Cutaneous Systemic Sclerosis (dcSSc) [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating tofacitinib for early diffuse cutaneous systemic sclerosis (dcSSc) has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-04-16Clinical Trial Update: Ablative Fractional Laser for Sclerotic GVHD-Associated Joint Contractures [NA]
A clinical trial evaluating ablative fractional laser for sclerotic graft-versus-host disease-associated joint contractures has been termina…
-
CLINICAL_TRIALS trial_result · 2020-04-10Clinical Trial Update: Treprostinil Iontophoresis in Systemic Sclerosis Digital UlcErations. A Proof of Concept Study [Phase 1, Phase 2]
A phase 1/2 proof-of-concept trial evaluating treprostinil delivered via iontophoresis for systemic sclerosis-related digital ulcers has com…
-
CLINICAL_TRIALS trial_result · 2020-02-18Clinical Trial Update: A Study of the Efficacy and Safety of Rituximab in Participants With Systemic Sclerosis [Phase 2, Phase 3]
A phase 2/3 clinical trial evaluating the efficacy and safety of rituximab in participants with systemic sclerosis (scleroderma) and related…
-
CLINICAL_TRIALS trial_result · 2020-02-12Clinical Trial Update: The Scleroderma Patient-centered Intervention Network (SPIN) Support Group Leader Education Program Feasibility Trial [NA]
Feasibility trial evaluating a leader education program for scleroderma support groups; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-12-13Clinical Trial Update: A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis [Phase 3]
Phase 3 trial comparing nintedanib to placebo in scleroderma-related lung fibrosis completed; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-10-18Clinical Trial Update: Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Patients With Systemic Sclerosis With Interstitial Lung Disease [Phase 2]
Phase 2 trial evaluating pomalidomide (CC-4047) for systemic sclerosis with interstitial lung disease was terminated; results posted in 2019…
-
CLINICAL_TRIALS trial_result · 2019-08-15Clinical Trial Update: Taking Charge of Systemic Sclerosis [NA]
Clinical trial update for systemic sclerosis (scleroderma) with completed status and posted results.
-
CLINICAL_TRIALS trial_result · 2019-07-05Clinical Trial Update: Scleroderma ARFI Imaging of the Skin
Clinical trial update on ARFI imaging of the skin in scleroderma has completed with results posted.